Peter G. Schultz
Affiliations: | 1985-1999 | University of California, Berkeley, Berkeley, CA, United States | |
| 1999- | Scripps Research Institute |
Website:
http://schultz.scripps.edu/schultz.phpGoogle:
"Peter G. Schultz"Bio:
http://www.nasonline.org/member-directory/members/64177.html
http://resolver.caltech.edu/CaltechETD:etd-06252004-112048
http://www.wolffund.org.il/index.php?dir=site&page=winners&cs=41&language=eng
The 1994/5 Wolf Prize in Chemistry: Richard A. Lerner and Peter G. Schultz for converting antibodies into enzymes, thus permitting the catalysis of chemical reactions considered impossible to achieve by classical chemical procedures.
Mean distance: 6.48 | S | N | B | C | P |
Parents
Sign in to add mentor| Peter B. Dervan | grad student | 1984 | Caltech | |
| (I. Ground and excited state studies of persistent 1,1-diazenes. II. Design of sequence specific DNA cleaving molecules) | ||||
| Christopher T. Walsh | post-doc | 1985 | MIT | |
Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dayan Elshan NGR, Wolff KC, Riva L, et al. (2024) Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead. Journal of Medicinal Chemistry |
| Grzelak EM, Elshan NGRD, Shao S, et al. (2023) Pharmacological YAP activation promotes regenerative repair of cutaneous wounds. Proceedings of the National Academy of Sciences of the United States of America. 120: e2305085120 |
| Ko Y, Hong M, Lee S, et al. (2023) S-lactoyl modification of KEAP1 by a reactive glycolytic metabolite activates NRF2 signaling. Proceedings of the National Academy of Sciences of the United States of America. 120: e2300763120 |
| Martínez-Peña F, Pearson AD, Tang EL, et al. (2022) Synthesis and biological evaluation of novel FiVe1 derivatives as potent and selective agents for the treatment of mesenchymal cancers. European Journal of Medicinal Chemistry. 242: 114638 |
| Wilburn KM, Montague CR, Qin B, et al. (2022) Pharmacological and genetic activation of cAMP synthesis disrupts cholesterol utilization in Mycobacterium tuberculosis. Plos Pathogens. 18: e1009862 |
| Lee SC, Ma JSY, Kim MS, et al. (2021) A PSMA-targeted bispecific antibody for prostate cancer driven by a small-molecule targeting ligand. Science Advances. 7 |
| Bakowski MA, Beutler N, Wolff KC, et al. (2021) Drug repurposing screens identify chemical entities for the development of COVID-19 interventions. Nature Communications. 12: 3309 |
| Shalhout SZ, Yang PY, Grzelak EM, et al. (2021) YAP-dependent proliferation by a small molecule targeting annexin A2. Nature Chemical Biology |
| Jo J, Ibrahim L, Iaconelli J, et al. (2021) Discovery and SAR studies of 3-amino-4-(phenylsulfonyl)tetrahydrothiophene 1,1-dioxides as non-electrophilic antioxidant response element (ARE) activators. Bioorganic Chemistry. 108: 104614 |
| Koh M, Ahmad I, Ko Y, et al. (2021) A short ORF-encoded transcriptional regulator. Proceedings of the National Academy of Sciences of the United States of America. 118 |